Mechanism based screen for retinoid X receptor agonists and antagonists
AssigneeAmerican Cyanamid Company
InventorsPaul Mak, Sotirios K. Karathanasis
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmerican Cyanamid Company
InventorsPaul Mak, Sotirios K. Karathanasis
Estimating the term…
A method is described for screening retinoid X receptor agonists or antagonists using a retinoid X receptor expressed by a yeast expression system to screen a compound having a retinoid X receptor agonist or antagonist activity. Another screen is described for detecting a compound having retinoid X receptor agonist or antagonist activity by: (1) providing a yeast strain which expresses the retinoic acid receptor and activates a reporter plasmid containing apolipoprotein AI gene site A or a mutated variant thereof; (2) incubating the compound in suitable media and a colorless chromogenic substrate; and (3) examining the media for development of color. Mutated variants of apolipoprotein AI gene site A which respond selectively to the retinoid X receptor or respond to receptors other than RXR.alpha. are also described.
A prokaryotic or eukaryotic host cell stably transformed or transfected by an expression vector containing a cDNA sequence encoding a retinoid X receptor and a reporter plasmid containing an apolipoprotein AI gene site A mutant comprising a nucleotide sequence selected from the group consisting of SEQ ID NOS:
An HB101 strain of E. coli carrying the reporter plasmid identified as M6!-41AI.CAT, having the ATCC designation number 69169.
An HB101 strain of E. coli carrying the reporter plasmid identified as M4!-41AI.CAT, having the ATCC designation number 69170.
An HB101 strain of E. coli carrying the reporter plasmid identified as M3!-41AI.CAT, having the ATCC designation number 69168.
A gene sequence comprising a nucleotide sequence comprising two TGACC imperfect direct repeats separated by the trinucleotide spacer CCT having the nucleotide sequence of SEQ ID NO:
A gene sequence comprising a nucleotide sequence comprising two TGACC imperfect direct repeats separated by the trinucleotide spacer TTT having the nucleotide sequence of SEQ ID NO:
Dependencies are inferred from the claim text.